Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1992 Sep 15;286(Pt 3):967–975. doi: 10.1042/bj2860967

Identification and characterization of aminopeptidases from Aplysia californica.

W Bawab 1, E Querido 1, P Crine 1, L DesGroseillers 1
PMCID: PMC1132997  PMID: 1417757

Abstract

Aminopeptidase activities were identified in extracts of kidney, ovotestis, head ganglia, heart and haemolymph of Aplysia californica. These enzyme preparations hydrolysed [3H][Leu]enkephalin at the Try-1-Gly-2 bond as determined by h.p.l.c. analysis of cleavage products. In all these tissues, enkephalin-degrading aminopeptidase activities were present both in membrane-bound and cytosolic fractions. The bivalent-cation-chelating agent, 1,10-phenanthroline, inhibited kidney membrane aminopeptidase activity with an IC50 of 30 microM, suggesting that this enzyme is a metalloproteinase. The aminopeptidase inhibitor amastatin was the most potent inhibitor of [Leu]enkephalin degradation (IC50 25 nM) by membrane-bound aminopeptidase, and bacitracin, bestatin and puromycin were about 100-1000 times less potent. In contrast with membrane-bound aminopeptidase, the cytosolic form is sensitive to puromycin. Angiotensin-converting enzyme inhibitor had no effect on [Leu]enkephalin degradation by kidney membranes, while the neutral endopeptidase inhibitors were poor inhibitors of the enzymes in this preparation. The Km values of the aminopeptidase in the kidney membranes and cytosolic fractions for the [Leu]enkephalin substrate were 2.4 and 7.4 microM respectively. The aminopeptidase present in the kidney membranes also hydrolysed endogenous Phe-Met-Arg-Phe-amide peptide at the Phe-1-Met-2 bond as well as synthetic alanine p-nitroanilide and leucine p-nitroanilide. When used in a competition assay, these substrates inhibited hydrolysis of [3H][Leu]enkephalin, suggesting that the same enzyme degraded all these substrates. Taken together, these results suggest that Aplysia tissues contain both a membrane-bound aminopeptidase related to the mammalian aminopeptidase N and a cytosolic puromycin-sensitive aminopeptidase.

Full text

PDF
967

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams T. W., Castellucci V. F., Camardo J. S., Kandel E. R., Lloyd P. E. Two endogenous neuropeptides modulate the gill and siphon withdrawal reflex in Aplysia by presynaptic facilitation involving cAMP-dependent closure of a serotonin-sensitive potassium channel. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7956–7960. doi: 10.1073/pnas.81.24.7956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amoscato A. A., Alexander J. W., Babcock G. F. Surface aminopeptidase activity of human lymphocytes. I. Biochemical and biologic properties of intact cells. J Immunol. 1989 Feb 15;142(4):1245–1252. [PubMed] [Google Scholar]
  3. Aoyagi T., Tobe H., Kojima F., Hamada M., Takeuchi T., Umezawa H. Amastatin, an inhibitor of aminopeptidase A, produced by actinomycetes. J Antibiot (Tokyo) 1978 Jun;31(6):636–638. doi: 10.7164/antibiotics.31.636. [DOI] [PubMed] [Google Scholar]
  4. Austin T., Weiss S., Lukowiak K. FMRFamide effects on spontaneous and induced contractions of the anterior gizzard in Aplysia. Can J Physiol Pharmacol. 1983 Aug;61(8):949–953. doi: 10.1139/y83-142. [DOI] [PubMed] [Google Scholar]
  5. Benter I. F., Hirsh E. M., Tuchman A. J., Ward P. E. N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid. Biochem Pharmacol. 1990 Aug 1;40(3):465–472. doi: 10.1016/0006-2952(90)90544-u. [DOI] [PubMed] [Google Scholar]
  6. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem. 1981 Feb 25;256(4):1604–1607. [PubMed] [Google Scholar]
  7. Brussaard A. B., Kits K. S., ter Maat A. One receptor type mediates two independent effects of FMRFa on neurosecretory cells of Lymnaea. Peptides. 1989 Mar-Apr;10(2):289–297. doi: 10.1016/0196-9781(89)90032-6. [DOI] [PubMed] [Google Scholar]
  8. Cawthorpe D., Lukowiak K. Dopamine and FMRFamide act directly on isolated gill muscle fibers in culture. Neurosci Lett. 1990 Jun 8;113(3):345–348. doi: 10.1016/0304-3940(90)90609-d. [DOI] [PubMed] [Google Scholar]
  9. Chaillet P., Marçais-Collado H., Costentin J., Yi C. C., De La Baume S., Schwartz J. C. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor. Eur J Pharmacol. 1983 Jan 21;86(3-4):329–336. doi: 10.1016/0014-2999(83)90181-4. [DOI] [PubMed] [Google Scholar]
  10. Crine P., LeGrimellec C., Lemieux E., Labonté L., Fortin S., Blachier A., Aubry M. The production and characterization of a monoclonal antibody specific for the 94,000 dalton enkephalin-degrading peptidase from rabbit kidney brush border. Biochem Biophys Res Commun. 1985 Aug 30;131(1):255–261. doi: 10.1016/0006-291x(85)91796-6. [DOI] [PubMed] [Google Scholar]
  11. Critz S. D., Baxter D. A., Byrne J. H. Modulatory effects of serotonin, FMRFamide, and myomodulin on the duration of action potentials, excitability, and membrane currents in tail sensory neurons of Aplysia. J Neurophysiol. 1991 Dec;66(6):1912–1926. doi: 10.1152/jn.1991.66.6.1912. [DOI] [PubMed] [Google Scholar]
  12. Devault A., Nault C., Zollinger M., Fournie-Zaluski M. C., Roques B. P., Crine P., Boileau G. Expression of neutral endopeptidase (enkephalinase) in heterologous COS-1 cells. Characterization of the recombinant enzyme and evidence for a glutamic acid residue at the active site. J Biol Chem. 1988 Mar 15;263(8):4033–4040. [PubMed] [Google Scholar]
  13. Dyer S. H., Slaughter C. A., Orth K., Moomaw C. R., Hersh L. B. Comparison of the soluble and membrane-bound forms of the puromycin-sensitive enkephalin-degrading aminopeptidases from rat. J Neurochem. 1990 Feb;54(2):547–554. doi: 10.1111/j.1471-4159.1990.tb01906.x. [DOI] [PubMed] [Google Scholar]
  14. Erdös E. G., Johnson A. R., Boyden N. T. Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase. Biochem Pharmacol. 1978 Mar 1;27(5):843–848. doi: 10.1016/0006-2952(78)90542-7. [DOI] [PubMed] [Google Scholar]
  15. Fournie-Zaluski M. C., Chaillet P., Bouboutou R., Coulaud A., Cherot P., Waksman G., Costentin J., Roques B. P. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes. Eur J Pharmacol. 1984 Jul 20;102(3-4):525–528. doi: 10.1016/0014-2999(84)90575-2. [DOI] [PubMed] [Google Scholar]
  16. Furuhashi M., Mizutani S., Kurauchi O., Kasugai M., Narita O., Tomoda Y. In vitro degradation of opioid peptides by human placental aminopeptidase M. Exp Clin Endocrinol. 1988 Dec;92(2):235–237. doi: 10.1055/s-0029-1210807. [DOI] [PubMed] [Google Scholar]
  17. Gorenstein C., Snyder S. H. Two distinct enkephalinases: solubilization, partial purification and separation from angiotensin converting enzyme. Life Sci. 1979 Dec 10;25(24-25):2065–2070. doi: 10.1016/0024-3205(79)90198-x. [DOI] [PubMed] [Google Scholar]
  18. Gorenstein C., Tran V. T., Snyder S. H. Brain peptidase with a unique neuronal localization: the histochemical distribution of dipeptidyl-aminopeptidase II. J Neurosci. 1981 Oct;1(10):1096–1102. doi: 10.1523/JNEUROSCI.01-10-01096.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Grafstein D. Coupled amino acid vestiges of the primordial genetic code. Orig Life. 1984;14(1-4):589–596. doi: 10.1007/BF00933708. [DOI] [PubMed] [Google Scholar]
  20. Grafstein D. Stereochemical origins of the genetic code. J Theor Biol. 1983 Nov 7;105(1):157–174. doi: 10.1016/0022-5193(83)90431-9. [DOI] [PubMed] [Google Scholar]
  21. Gros C., Giros B., Schwartz J. C. Identification of aminopeptidase M as an enkephalin-inactivating enzyme in rat cerebral membranes. Biochemistry. 1985 Apr 23;24(9):2179–2185. doi: 10.1021/bi00330a011. [DOI] [PubMed] [Google Scholar]
  22. Haines TJ, Bionta RM, Blewitt G, Bratton CB, Casper D, Claus R, Cortez BG, Errede S, Foster GW, Gajewski W. Calculation of atmospheric neutrino-induced backgrounds in a nucleon-decay search. Phys Rev Lett. 1986 Oct 20;57(16):1986–1989. doi: 10.1103/PhysRevLett.57.1986. [DOI] [PubMed] [Google Scholar]
  23. Hall J. D., Lloyd P. E. Involvement of pedal peptide in locomotion in Aplysia: modulation of foot muscle contractions. J Neurobiol. 1990 Sep;21(6):858–868. doi: 10.1002/neu.480210604. [DOI] [PubMed] [Google Scholar]
  24. Hersh L. B. Characterization of membrane-bound aminopeptidases from rat brain: identification of the enkephalin-degrading aminopeptidase. J Neurochem. 1985 May;44(5):1427–1435. doi: 10.1111/j.1471-4159.1985.tb08779.x. [DOI] [PubMed] [Google Scholar]
  25. Hersh L. B. Solubilization and characterization of two rat brain membrane-bound aminopeptidases active on Met-enkephalin. Biochemistry. 1981 Apr 14;20(8):2345–2350. doi: 10.1021/bi00511a042. [DOI] [PubMed] [Google Scholar]
  26. Hui K. S., Hui M. P., Lajtha A. Major rat brain membrane-associated and cytosolic enkephalin-degrading aminopeptidases: comparison studies. J Neurosci Res. 1988;20(2):231–240. doi: 10.1002/jnr.490200212. [DOI] [PubMed] [Google Scholar]
  27. Hui K. S., Wang Y. J., Lajtha A. Purification and characterization of an enkephalin aminopeptidase from rat brain membranes. Biochemistry. 1983 Mar 1;22(5):1062–1067. doi: 10.1021/bi00274a010. [DOI] [PubMed] [Google Scholar]
  28. Ichinose M., McAdoo D. J. The voltage-dependent, slow inward current induced by the neuropeptide FMRFamide in Aplysia neuron R14. J Neurosci. 1988 Oct;8(10):3891–3900. doi: 10.1523/JNEUROSCI.08-10-03891.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kenny A. J., Maroux S. Topology of microvillar membrance hydrolases of kidney and intestine. Physiol Rev. 1982 Jan;62(1):91–128. doi: 10.1152/physrev.1982.62.1.91. [DOI] [PubMed] [Google Scholar]
  30. Kerr M. A., Kenny A. J. The molecular weight and properties of a neutral metallo-endopeptidase from rabbit kidney brush border. Biochem J. 1974 Mar;137(3):489–495. doi: 10.1042/bj1370489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Little G. H., Starnes W. L., Behal F. J. Human liver aminopeptidase. Methods Enzymol. 1976;45:495–503. doi: 10.1016/s0076-6879(76)45044-9. [DOI] [PubMed] [Google Scholar]
  32. Llorens C., Malfroy B., Schwartz J. C., Gacel G., Roques B. P., Roy J., Morgat J. L., Javoy-Agid F., Agid Y. Enkephalin dipeptidyl carboxypeptidase (enkephalinase) activity: selective radioassay, properties, and regional distribution in human brain. J Neurochem. 1982 Oct;39(4):1081–1089. doi: 10.1111/j.1471-4159.1982.tb11500.x. [DOI] [PubMed] [Google Scholar]
  33. Maeda T., Balakrishnan K., Mehdi S. Q. A simple and rapid method for the preparation of plasma membranes. Biochim Biophys Acta. 1983 May 26;731(1):115–120. doi: 10.1016/0005-2736(83)90404-2. [DOI] [PubMed] [Google Scholar]
  34. Malfroy B., Swerts J. P., Guyon A., Roques B. P., Schwartz J. C. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature. 1978 Nov 30;276(5687):523–526. doi: 10.1038/276523a0. [DOI] [PubMed] [Google Scholar]
  35. Mantle D., Lauffart B., McDermott J., Gibson A. Characterization of aminopeptidases in human kidney soluble fraction. Clin Chim Acta. 1990 Feb 28;187(2):105–113. doi: 10.1016/0009-8981(90)90336-q. [DOI] [PubMed] [Google Scholar]
  36. Matsas R., Stephenson S. L., Hryszko J., Kenny A. J., Turner A. J. The metabolism of neuropeptides. Phase separation of synaptic membrane preparations with Triton X-114 reveals the presence of aminopeptidase N. Biochem J. 1985 Oct 15;231(2):445–449. doi: 10.1042/bj2310445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. McLellan S., Dyer S. H., Rodriguez G., Hersh L. B. Studies on the tissue distribution of the puromycin-sensitive enkephalin-degrading aminopeptidases. J Neurochem. 1988 Nov;51(5):1552–1559. doi: 10.1111/j.1471-4159.1988.tb01124.x. [DOI] [PubMed] [Google Scholar]
  38. Montecucchi P. C., de Castiglione R., Piani S., Gozzini L., Erspamer V. Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin of Phyllomedusa sauvagei. Int J Pept Protein Res. 1981 Mar;17(3):275–283. doi: 10.1111/j.1399-3011.1981.tb01993.x. [DOI] [PubMed] [Google Scholar]
  39. Ocorr K. A., Byrne J. H. Membrane responses and changes in cAMP levels in Aplysia sensory neurons produced by serotonin, tryptamine, FMRFamide and small cardioactive peptideB (SCPB). Neurosci Lett. 1985 Apr 9;55(2):113–118. doi: 10.1016/0304-3940(85)90004-7. [DOI] [PubMed] [Google Scholar]
  40. Palmieri F. E., Bausback H. H., Ward P. E. Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M. Biochem Pharmacol. 1989 Jan 1;38(1):173–180. doi: 10.1016/0006-2952(89)90165-2. [DOI] [PubMed] [Google Scholar]
  41. Patey G., De La Baume S., Schwartz J. C., Gros C., Roques B., Fournie-Zaluski M. C., Soroca-Lucas E. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition. Science. 1981 Jun 5;212(4499):1153–1155. doi: 10.1126/science.7015510. [DOI] [PubMed] [Google Scholar]
  42. Payza K. FMRFamide receptors in Helix aspersa. Peptides. 1987 Nov-Dec;8(6):1065–1074. doi: 10.1016/0196-9781(87)90138-0. [DOI] [PubMed] [Google Scholar]
  43. Pert C. B., Pert A., Chang J. K., Fong B. T. (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic. Science. 1976 Oct 15;194(4262):330–332. doi: 10.1126/science.968485. [DOI] [PubMed] [Google Scholar]
  44. Richmond J. E., Bulloch A. G., Lukowiak K. Peptidergic modulation of a neuromuscular junction in Aplysia: bioactivity and immunocytochemistry. Brain Res. 1986 Apr 2;370(1):159–164. doi: 10.1016/0006-8993(86)91117-0. [DOI] [PubMed] [Google Scholar]
  45. Roques B. P., Fournié-Zaluski M. C., Soroca E., Lecomte J. M., Malfroy B., Llorens C., Schwartz J. C. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature. 1980 Nov 20;288(5788):286–288. doi: 10.1038/288286a0. [DOI] [PubMed] [Google Scholar]
  46. Schwartz J. C., Malfroy B., De La Baume S. Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase ("enkephalinase") as neuropeptidase. Life Sci. 1981 Oct 26;29(17):1715–1740. doi: 10.1016/0024-3205(81)90182-x. [DOI] [PubMed] [Google Scholar]
  47. Shipp M. A., Stefano G. B., D'Adamio L., Switzer S. N., Howard F. D., Sinisterra J., Scharrer B., Reinherz E. L. Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature. 1990 Sep 27;347(6291):394–396. doi: 10.1038/347394a0. [DOI] [PubMed] [Google Scholar]
  48. Squire C. R., Talebian M., Menon J. G., Dekruyff S., Lee T. D., Shively J. E., Rothman B. S. Leucine aminopeptidase-like activity in Aplysia hemolymph rapidly degrades biologically active alpha-bag cell peptide fragments. J Biol Chem. 1991 Nov 25;266(33):22355–22363. [PubMed] [Google Scholar]
  49. Sullivan S., Akil H., Barchas J. D. In vitro degradation of enkephalin: evidence for cleavage at the Gly-Phe bond. Commun Psychopharmacol. 1978;2(6):525–531. [PubMed] [Google Scholar]
  50. Taussig R., Scheller R. H. The Aplysia FMRFamide gene encodes sequences related to mammalian brain peptides. DNA. 1986 Dec;5(6):453–461. doi: 10.1089/dna.1.1986.5.453. [DOI] [PubMed] [Google Scholar]
  51. Thompson S., Ruben P. Inward rectification in response to FMRFamide in Aplysia neuron L2: summation with transient K current. J Neurosci. 1988 Sep;8(9):3200–3207. doi: 10.1523/JNEUROSCI.08-09-03200.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Waksman G., Bouboutou R., Devin J., Besselievre R., Fournie-Zaluski M. C., Roques B. P. Binding of the bidentate inhibitor [3H]HACBO-Gly to the rat brain neutral endopeptidase "enkephalinase". Biochem Biophys Res Commun. 1985 Aug 30;131(1):262–268. doi: 10.1016/0006-291x(85)91797-8. [DOI] [PubMed] [Google Scholar]
  53. Weiss S., Goldberg J. I., Chohan K. S., Stell W. K., Drummond G. I., Lukowiak K. Evidence for FMRF-amide as a neurotransmitter in the gill of Aplysia californica. J Neurosci. 1984 Aug;4(8):1994–2000. doi: 10.1523/JNEUROSCI.04-08-01994.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wickham L., Desgroseillers L. A bradykinin-like neuropeptide precursor gene is expressed in neuron L5 of Aplysia californica. DNA Cell Biol. 1991 May;10(4):249–258. doi: 10.1089/dna.1991.10.249. [DOI] [PubMed] [Google Scholar]
  55. Wilkes S. H., Prescott J. M. The slow, tight binding of bestatin and amastatin to aminopeptidases. J Biol Chem. 1985 Oct 25;260(24):13154–13162. [PubMed] [Google Scholar]
  56. Zhang A. Z., Yang H. Y., Costa E. Nociception, enkephalin content and dipeptidyl carboxypeptidase activity in brain of mice treated with exopeptidase inhibitors. Neuropharmacology. 1982 Jul;21(7):625–630. doi: 10.1016/0028-3908(82)90004-1. [DOI] [PubMed] [Google Scholar]
  57. de la Baume S., Yi C. C., Schwartz J. C., Chaillet P., Marcais-Collado H., Costentin J. Participation of both 'enkephalinase' and aminopeptidase activities in the metabolism of endogenous enkephalins. Neuroscience. 1983 Jan;8(1):143–151. doi: 10.1016/0306-4522(83)90033-7. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES